These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36339382)

  • 21. [Utility of mouth rinses with povidone-iodine and hydrogen peroxide in patients with COVID-19].
    Pablo-Marcos D; Abascal B; Lloret L; Gutiérrez Cuadra M; Velasco N; Valero C
    Enferm Infecc Microbiol Clin; 2023 Mar; 41(3):173-175. PubMed ID: 34720312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential Oils as Antiviral Agents. Potential of Essential Oils to Treat SARS-CoV-2 Infection: An
    Silva JKRD; Figueiredo PLB; Byler KG; Setzer WN
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32408699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential SARS-COV preclinical (in vivo) compounds targeting COVID-19 main protease: a meta-analysis and molecular docking studies.
    Ebenezer O; Jordaan MA; Ogunsakin RE; Shapi M
    Hippokratia; 2020; 24(3):99-106. PubMed ID: 34239286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    J Biomol Struct Dyn; 2023; 41(13):5915-5945. PubMed ID: 35848354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CL
    Koulgi S; Jani V; Uppuladinne M; Sonavane U; Nath AK; Darbari H; Joshi R
    J Biomol Struct Dyn; 2021 Sep; 39(15):5735-5755. PubMed ID: 32679006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
    Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
    Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2.
    Kandeil A; Mostafa A; Kutkat O; Moatasim Y; Al-Karmalawy AA; Rashad AA; Kayed AE; Kayed AE; El-Shesheny R; Kayali G; Ali MA
    Pathogens; 2021 Jun; 10(6):. PubMed ID: 34203977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases.
    Arouche TDS; Martins AY; Ramalho TC; Júnior RNC; Costa FLP; Filho TSA; Neto AMJC
    J Nanosci Nanotechnol; 2021 Apr; 21(4):2075-2089. PubMed ID: 33500022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective
    Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
    J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
    Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.
    Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF
    Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of mouthrinses on severe acute respiratory syndrome coronavirus 2 viral load: A systematic review.
    Silva A; Azevedo M; Sampaio-Maia B; Sousa-Pinto B
    J Am Dent Assoc; 2022 Jul; 153(7):635-648.e16. PubMed ID: 35287944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the oral cavity relevant in SARS-CoV-2 pandemic?
    Herrera D; Serrano J; Roldán S; Sanz M
    Clin Oral Investig; 2020 Aug; 24(8):2925-2930. PubMed ID: 32577830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 in environmental perspective: Occurrence, persistence, surveillance, inactivation and challenges.
    Mohan SV; Hemalatha M; Kopperi H; Ranjith I; Kumar AK
    Chem Eng J; 2021 Feb; 405():126893. PubMed ID: 32901196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of the use of nasal and oral antiseptics during a global pandemic.
    Stathis C; Victoria N; Loomis K; Nguyen SA; Eggers M; Septimus E; Safdar N
    Future Microbiol; 2021 Jan; 16(2):119-130. PubMed ID: 33464122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease.
    Oso BJ; Olaoye IF; Omeike SO
    Arch Razi Inst; 2021; 76(3):453-459. PubMed ID: 34824739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of povidone-iodine and chlorhexidine mouth rinses on plaque Streptococcus mutans count in 6- to 12-year-old school children: an in vivo study.
    Neeraja R; Anantharaj A; Praveen P; Karthik V; Vinitha M
    J Indian Soc Pedod Prev Dent; 2008 Jan; 26 Suppl 1():S14-8. PubMed ID: 18974539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse.
    Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
    J Prosthodont; 2020 Jul; 29(6):529-533. PubMed ID: 32511851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay.
    Pitsillou E; Liang J; Karagiannis C; Ververis K; Darmawan KK; Ng K; Hung A; Karagiannis TC
    Comput Biol Chem; 2020 Dec; 89():107408. PubMed ID: 33137690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the Binding Affinity of Anti-Viral Drugs against Main Protease of SARS-CoV-2 Through a Molecular Docking Study.
    Mondal M; Sarkar C; Jamaddar S; Khalipha ABR; Islam MT; Mahafzah A; Mubarak MS
    Infect Disord Drug Targets; 2021; 21(7):e160921188777. PubMed ID: 33292147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.